ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
02 janv. 2024 09h15 HE
|
Elevai Labs Inc.
ELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry Conferences
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
11 déc. 2023 09h15 HE
|
Elevai Labs Inc.
Elevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023
NurExone Biologic Extends Spinal Cord Injury Therapy Portfolio With New RNA Sequences Promoting Healing and Regeneration
29 nov. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone Biologic expands its portfolio of products to address spinal cord injuries & neuron regeneration in CNS indications
NurExone Biologic to Present Exosome-Based Therapy for Spinal Cord Injury in Regenerative Medicine Session at Upcoming Extracellular Vesicles Forum
05 oct. 2023 08h30 HE
|
NurExone Biologic Inc
NurExone Biologic will present at the EVs Forum in Cambridge presents advances in exosome therapy for spinal cord injuries, highlighting ExoPTEN potential
Exosomes Market Size to Surpass USD 2,707.8 million by 2032 at Sustained CAGR of 34.2% - Market.us Study
08 mai 2023 09h29 HE
|
Market.Us
New York, May 08, 2023 (GLOBE NEWSWIRE) -- The exosomes market size is projected to surpass around USD 2,707.8 Million by 2032 and it is poised to reach a CAGR of 34.2% from 2023 to 2032. The global...
Exosome Technologies Market Value to Reach USD 343.5 Mn by 2031, rising at a CAGR of 24.8%: TMR Study
05 mai 2023 08h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global exosome technologies market was valued at USD 47.3 Mn in 2022 and is projected to exceed USD 343.5 Mn by 2031. ...
NurExone Biologic Reports Additional Positive Preclinical Trial Outcomes with ExoPTEN: 75% of Paralyzed Rats Show Recovery after Acute Spinal Cord Injury Study
20 mars 2023 07h58 HE
|
NurExone
TORONTO and TEL AVIV, Israel, March 20, 2023 (GLOBE NEWSWIRE) -- Toronto and Tel Aviv, March 20, 2023 - Biopharmaceutical firm NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (“NurExone” or...
Global Acellular Therapy Market Size Was Valued at $8.451 Billion in 2022 and Is Projected to Surpass Around $32.61 Billion Mark by 2030, Growing at a CAGR of 16.21%
16 mars 2023 07h02 HE
|
Zion Market Research
Washington, DC, March 16, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Acellular Therapy Market By Disease (Parkinson’s, Alzeihmer’s, Chronic Wounds,...
US Exosome Research Products Market Is Projected To Reach US$ 1.9 Billion, Advancing Rapidly At A CAGR Of 20.8% - Fact.MR Report
11 janv. 2023 06h30 HE
|
FACT.MR
Rockville, Jan. 11, 2023 (GLOBE NEWSWIRE) -- As per a recently published industry report by Fact.MR, a provider of market research and competitive intelligence, the global exosome research products...
The exosome therapeutics market is projected to grow at an annualized rate of 41%, claims Roots Analysis
13 déc. 2022 09h00 HE
|
Roots Analysis
London, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Exosome Therapeutics Market, 2022-2040” report to its list of offerings. With the advancements in...